2025-12-28 - Analysis Report
Okay, here's a comprehensive analysis of Procter & Gamble (PG) based on the data provided.

**1) Return Rate Comparison and Alpha/Beta Analysis:**

*   **Company Overview:** Procter & Gamble Co. is a multinational consumer goods corporation providing a wide range of branded products.
*   **Cumulative Return:**
    *   PG: 26.38%
    *   S&P 500 (VOO): 103.21%
*   **Divergence:** -74.8 (Relative Divergence: 5.3)
*   **Analysis:** PG has significantly underperformed the S&P 500 over the period represented by the cumulative returns. The large negative divergence and low relative divergence indicates PG's performance is closer to its historical low compared to the S&P 500.

**Alpha/Beta Analysis Table:**

| Year       | CAGR   | MDD    | Alpha  | Beta | Cap(B) |
|------------|--------|--------|--------|------|--------|
| 2015-2017  | 21.0%  | 7.9%   | -8.0%  | 0.0  | 215.0  |
| 2016-2018  | 9.0%   | 67.3%  | -6.0%  | 0.1  | 215.1  |
| 2017-2019  | 24.0%  | 70.4%  | 2.0%   | 0.3  | 292.3  |
| 2018-2020  | 27.0%  | 78.8%  | 4.0%   | 0.4  | 325.7  |
| 2019-2021  | 41.0%  | 78.8%  | -5.0%  | 0.5  | 382.9  |
| 2020-2022  | 13.0%  | 79.4%  | 13.0%  | 0.6  | 354.7  |
| 2021-2023  | 26.0%  | 79.4%  | 24.0%  | 0.4  | 343.0  |
| 2022-2024  | 9.0%   | 79.4%  | -12.0% | 0.4  | 392.4  |
| 2023-2025  | -18.0% | 80.1%  | -85.0% | 0.1  | 338.8  |

*   **Analysis:**
    *   **CAGR (Compound Annual Growth Rate):** Fluctuates significantly, with a negative CAGR in the most recent period (2023-2025).
    *   **MDD (Maximum Drawdown):** High MDD values indicate substantial potential losses within each period, especially in recent years.
    *   **Alpha:**  A measure of performance on a risk-adjusted basis, relative to a benchmark. The negative Alpha values in several periods suggest underperformance relative to the benchmark. 2023-2025 has a significantly negative Alpha.
    *   **Beta:** Measures the volatility of a stock compared to the market. Beta values generally below 1 indicate PG is less volatile than the market.
    *   **Cap(B):** Market capitalization in Billions, shows fluctuation, reflecting changing investor sentiment and performance.

**2) Recent Stock Price Fluctuations:**

*   **Current Price:** 144.74
*   **Previous Close:** 144.49
*   **Change:** 0.17
*   **5-day SMA:** 143.91
*   **20-day SMA:** 143.93
*   **60-day SMA:** 147.43

*   **Analysis:** The current price is slightly above the previous close, indicating a minor increase. The 5-day and 20-day SMAs are close, suggesting relatively stable short-term price movement. The 60-day SMA is higher than the shorter-term SMAs, indicating a recent downward trend.

**3) RSI, PPO, MRI, and Hybrid Signal:**

*   **MRI (Market Risk Indicator):** 1.0 (High Investment Recommended)
*   **RSI (Relative Strength Index):** 52.97 (Neutral - neither overbought nor oversold)
*   **PPO (Percentage Price Oscillator):** 0.21 (Slightly Bullish)
*   **Hybrid Signal:** Buy 100% of cash (7 shares - Very Safe). Monthly invest 0.8% of total investment ($1,000). Cash Ratio: 0% on 2025-12-01.
*   **Recent Relative Divergence Change:** 1.0 (+): Short-term Increase
*   **Expected Return:** -0.5% (Negative excess return compared to S&P 500 if invested long-term)

*   **Analysis:** Despite the "High Investment Recommended" from the MRI, the negative expected return suggests caution. The RSI indicates a neutral condition, while the PPO suggests a slight bullish momentum. The Hybrid Signal is recommending a full investment (7 shares). The recent divergence change indicates a short-term increase, but the longer-term view is less optimistic.

**4) Recent News & Significant Events:**

*   **Key Themes:**
    *   **Recent Price Pullback:** Several articles discuss the recent price pullback in PG stock.
    *   **Value Opportunity?:** Some articles question whether the pullback presents a value opportunity.
    *   **Analyst/Fund Actions:** There's mention of analyst opinions and fund managers cutting holdings.
    *   **2-Year Low:** PG stock hit a 2-year low recently.

*   **Impact:** The news suggests some uncertainty and concern around PG's recent performance, but also hints at potential value depending on an investor's perspective.

**4-2) Analyst Opinions:**

*   **Consensus:** Buy (Mean: 1.92)
*   **Target Price:** 168.95 (Avg), 186.00 (High), 148.00 (Low)
*   **Analysis:**  The analyst consensus is "Buy" with an average target price significantly above the current price. This suggests analysts believe the stock is undervalued. However, the range between high and low target prices indicates some disagreement. Recent rating changes are not provided.

**5) Recent Earnings Analysis:**

| 날짜       | EPS  | 매출       |
|------------|------|------------|
| 2025-10-24 | 2    | 22.39 B$ |
| 2025-04-24 | 1.58 | 19.78 B$ |
| 2025-01-22 | 1.94 | 21.88 B$ |
| 2024-10-18 | 1.65 | 21.74 B$ |
| 2025-10-24 | 1.65 | 21.74 B$ |

*   **Analysis:** Revenue has fluctuated over the past few quarters, with some growth. EPS also shows some volatility. Note that the last row appears to be a duplicate, which could indicate a data error.

**6) Financial Information - Revenue, Profitability, Capital & ROE:**

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|---------------|
| 2025-09-30   | $22.39B   | 51.37%        |
| 2025-06-30   | $20.89B   | 49.11%        |
| 2025-03-31   | $19.78B   | 50.98%        |
| 2024-12-31   | $21.88B   | 52.39%        |
| 2024-09-30   | $21.74B   | 52.06%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE     |
|--------------|-----------|---------|
| 2025-09-30   | $53.27B   | 8.92%   |
| 2025-06-30   | $52.01B   | 6.95%   |
| 2025-03-31   | $52.27B   | 7.21%   |
| 2024-12-31   | $51.17B   | 9.05%   |
| 2024-09-30   | $51.84B   | 7.64%   |

*   **Analysis:**
    *   **Revenue:** Shows some quarter-to-quarter variation.
    *   **Profit Margin:** Relatively stable in the high 40s to low 50s percentage range, indicating strong profitability.
    *   **Equity:**  Gradually increasing.
    *   **ROE (Return on Equity):** Fluctuates, indicating variations in how effectively the company is using equity to generate profits.

**7) Comprehensive Analysis (Summary):**

Procter & Gamble's recent performance paints a mixed picture:

*   **Underperformance:** PG has significantly underperformed the S&P 500, and the recent CAGR is negative.
*   **Price Pullback and Uncertainty:**  Recent news highlights a price pullback, leading to questions about value.
*   **Analyst Optimism:**  Analysts, on average, have a "Buy" rating and a target price well above the current level.
*   **Short-Term Increase Signal:** Recent relative divergence suggests a potential short-term increase.
*   **High Investment Recommended:** The MRI suggests a high investment recommendation, while the expected excess return compared to S&P 500 if invested long-term is negative (-0.5%).
*   **Strong Financials:** Despite the stock performance challenges, PG exhibits strong profit margins and a growing equity base. The recent earnings indicate the company is still profitable, but growth is not exceptional.
*   **Hybrid Signal:**  Buy 100% of cash (7 shares - Very Safe)

**Overall Conclusion:**

PG appears to be facing headwinds reflected in its underperformance relative to the S&P 500 and the recent price decline. While some indicators point to a potential short-term rebound, the negative expected return suggests caution for long-term investors.

However, strong profit margins, a growing equity base, and the analyst consensus suggest that the stock could be undervalued. Investors need to carefully consider their risk tolerance and investment horizon when evaluating PG.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.